View Merck & Co., Inc. MRK stock quote prices, financial information, real-time forecasts, and company news from CNN.

Merck falls 7% despite an earnings beat as a pipeline setback and Gardasil weakness act as dampeners. However, Keytruda and new launches support growth.

Merck (MRK) shares rose nearly 5% in early trade on Friday after the company said a European medicines committee issued a ...

A bullish diagonal spread is an advanced option trade and generally not suitable for beginners, but it can have its place within an option portfolio. It is a bullish strategy that benefits from time ...

Merck (NYSE:MRK) delivered its fourth consecutive earnings beat, but shares slipped on the earnings report. With acquisition ...

・Merck’s widely used immunotherapy, Keytruda, drove the company’s topline growth during the quarter, accounting for nearly half of Merck’s total sales during this period. ・Keytruda sales during Q1 ...

Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.

Merck (MRK) has drawn fresh investor attention after a mixed stretch in its share performance, including a 1 day dip, a wider pullback over the past month, and a modest gain over the past 3 months.